| # | Drug | Count |
|---|---|---|
| 0 | DORNASE ALFA | 1776 |
| 1 | TOBRAMYCIN | 1283 |
| 2 | ALBUTEROL SULFATE | 806 |
| 3 | PANCRELIPASE | 796 |
| 4 | SODIUM CHLORIDE | 543 |
| 5 | SODIUM CHLORIDE TABLET | 531 |
| 6 | SODIUM CHLORIDE TABLETS | 531 |
| 7 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 513 |
| 8 | TOBRAMYCIN SULFATE | 430 |
| 9 | TOBRAMYCIN SOLUTION | 418 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AQUAVIT | 1 | 0.5000 |
| 1 | DORNASE ALFA | 1776 | 0.0905 |
| 2 | SODIUM SULFACETAMIDE 9.8% AND SULFUR 4.8% | 1 | 0.0667 |
| 3 | TOBRAMYCIN | 1283 | 0.0544 |
| 4 | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE | 287 | 0.0476 |
| 5 | SODIUM SULFACETAMIDE AND SULFUR | 1 | 0.0476 |
| 6 | SODIUM SULFACETAMIDE, SULFUR | 1 | 0.0476 |
| 7 | COLISTIMETHATE SODIUM | 67 | 0.0414 |
| 8 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 513 | 0.0408 |
| 9 | AZTREONAM | 287 | 0.0398 |
| # | Drug class | Count |
|---|---|---|
| 0 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1776 |
| 1 | Aminoglycoside Antibacterial [EPC] | 1327 |
| 2 | Osmotic Laxative [EPC] | 655 |
| 3 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 565 |
| 4 | Corticosteroid [EPC] | 501 |
| 5 | Proton Pump Inhibitor [EPC] | 447 |
| 6 | Insulin Analog [EPC] | 288 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 181 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 180 |
| 9 | Benzodiazepine [EPC] | 165 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1776 | 0.0905 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 565 | 0.0327 |
| 2 | Aminoglycoside Antibacterial [EPC] | 1327 | 0.0298 |
| 3 | Vitamin B6 Analog [EPC] | 4 | 0.0110 |
| 4 | Vitamin K [EPC] | 69 | 0.0080 |
| 5 | Monobactam Antibacterial [EPC] | 18 | 0.0066 |
| 6 | Bile Acid [EPC] | 146 | 0.0063 |
| 7 | Serotonin-4 Receptor Agonist [EPC] | 3 | 0.0046 |
| 8 | Antihypoglycemic Agent [EPC] | 14 | 0.0033 |
| 9 | Cannabinoid [EPC] | 22 | 0.0027 |